Two coronavirus vaccines begin the last phase of testing: 30,000-person trials

The first participants received shots in a 30,000-person trial of an experimental vaccine being developed by biotech company Moderna in partnership with the U.S. government.

Source: Washington Post: To Your Health - July 28, 2020 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news